Colin Groot receives ERC Starting Grant for research on biomarkers in dementiaResearcher Colin Groot of Alzheimer Center Amsterdam and the department of Neurology at Amsterdam UMC has been awarded an ERC starting grant of 2,5 million euro. With this grant he will investigate how reliable biomarkers can be for detecting and tracking brain diseases that cause dementia.
Breakthrough trial offers first hope for children with Vanishing White Matter diseaseA team of researchers from the Amsterdam Leukodystrophy Center at Amsterdam UMC, led by Prof. Marjo van der Knaap, has published the first clinical evidence that the drug guanabenz may alter the course of vanishing white matter disease (VWM), a devastating childhood neurodegenerative disorder for which no effective treatment previously existed. The findings from the neuroscientists of this phase 1/2 trial have now been published in The Lancet Neurology.
Kim de Kleijn and Femke Feringa receive Alzheimer Nederland Research Talent AwardTwo Alzheimer researchers from Amsterdam Neuroscience have received the Research Talent Award from Alzheimer Nederland. The award supports young, talented researchers at the beginning of their careers in continuing and expanding their research.
